Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine.

Madesh S, McGill J, Jaworski DC, Ferm J, Ferm D, Liu H, Fitzwater S, Nair A, Hove P, Alizadeh K, Knox C, Thackrah A, Ganta RR

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

Consistency in Identifying Atrial Septal Aneurysm in PFO-Associated Stroke Patients: A Single-Center Experience.

Alzahrani A, Alizadeh K, Shaikh N, Kass M, Shah AH

Evaluation of variations in predominant gut microbiota members in inflammatory bowel disease using real-time PCR.

Tasoujlu M, Sharifi Y, Ghahremani M, Alizadeh K, Babaie F, Hosseiniazar MM

Long-Term Protective Immunity against Ehrlichia chaffeensis Infection Induced by a Genetically Modified Live Vaccine.

Madesh S, McGill J, Jaworski DC, Ferm J, Liu H, Fitzwater S, Hove P, Ferm D, Nair A, Knox CA, Alizadeh K, Thackrah A, Ganta RR

Therapeutic potential of berries in age-related neurological disorders.

Norouzkhani N, Afshari S, Sadatmadani SF, Mollaqasem MM, Mosadeghi S, Ghadri H, Fazlizade S, Alizadeh K, Akbari Javar P, Amiri H, Foroughi E, Ansari A, Mousazadeh K, Davany BA, Akhtari Kohnehshahri A, Alizadeh A, Dadkhah PA, Poudineh M

Northwest Iranian dermatophyte isolates: anthropophilic and geophilic.

Diba K, Jafari K, Alizadeh K, Aslani N

Permanent Pacemaker-Mediated Exertional Hypoxemia in a Patient With Ebstein Anomaly.

Shah AH, Shaikh N, Alizadeh K, Khadem A, Khoo C, Ducas RA, Kass M

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

A new optical pH sensor based on a mixture of Alizarin and Orange dyes immobilized on an agarose membrane.

Alizadeh K, Rezaei B, Nemati H

Development of Composite Sponge Scaffolds Based on Carrageenan (CRG) and Cerium Oxide Nanoparticles (CeO(2) NPs) for Hemostatic Applications.

Alizadeh K, Dezvare Y, Kamyab S, Amirian J, Brangule A, Bandere D

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, RECOVERY Collaborative Group

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.

Shah PL, Orton CM, Grinsztejn B, Donaldson GC, Crabtree RamĂ­rez B, Tonkin J, Santos BR, Cardoso SW, Ritchie AI, Conway F, Riberio MPD, Wiseman DJ, Tana A, Vijayakumar B, Caneja C, Leaper C, Mann B, Samson A, Bhavsar PK, Boffito M, Johnson MR, Pozniak A, Pelly M, PIONEER trial group

Improvement in Essential Oil Quantity and Quality of Thyme (Thymus vulgaris L.) by Integrative Application of Chitosan Nanoparticles and Arbuscular Mycorrhizal Fungi under Water Stress Conditions.

Amani Machiani M, Javanmard A, Ostadi A, Alizadeh K